Aetna named Press Ganey’s inaugural Health Plan of the Year
Press Ganey’s inaugural Health Plan of the Year award honors Aetna’s sustained excellence in member experience, quality, and provider collaboration.
Press Ganey’s inaugural Health Plan of the Year award honors Aetna’s sustained excellence in member experience, quality, and provider collaboration.
For pharmacy operators and healthcare stakeholders, the findings emphasize the need to maintain access to screening, timely referrals, and ongoing care during public health emergencies, especially for high-risk and newly diagnosed patients.
CVS Caremark stated that the change expands its broader biosimilar strategy.
The milestone also comes just days after John Furner assumed the role of CEO, succeeding longtime chief executive Doug McMillon.
The report highlights online and direct-to-consumer channels as the fastest-growing sales segment, driven by subscription models, broader product range, and increased digital health engagement.
The AI-powered digital hub helps pharma engage providers and patients, streamlining medication access and adherence.
“While these reforms begin to address one of the most significant challenges pharmacists face under Medicare, they represent only part of what’s needed,” says APhA CEO.
In 2025, prime delivery speeds hit record levels. Amazon uses the same infrastructure to expedite prescription delivery.
Motif is a compact, semi-automated tabletop strip packager that delivers enterprise-level accuracy without requiring pharmacy renovations.
This week’s House vote will decide whether long-promised changes become law or are postponed again.
A collagen-infused pop-up celebrating the people who power Fashion Week, with a “major” collaboration from Patrick Ta.
Upgraded whey protein powder delivers 50g protein, 6.2g leucine, improved flavor and third-party certifications for label accuracy and sport safety, now featured in The Drop, by GNC.
The rising demand for clean-label, plant-based, personalized sports nutrition products is transforming the U.S. market.
The $3.5 billion Lehigh Valley site will develop Lilly's next-generation weight-loss medicines, including retatrutide.
The U.S. Department of Labor has proposed a regulation that represents the most substantial federal PBM reform in many years.
“It is an honor to serve as AAM board chair, and I thank the board for the privilege,” said Bob Hoffman.